The Mid-Market Validation Gap — an Economic Whitepaper

The structural problem

Regulation does not scale with company size. A Series B biotech deploying a LIMS faces the same Annex 11 and Part 11 expectations as a top-twenty manufacturer deploying the same product. What differs is everything around the obligation: the large manufacturer has a validation department, established templates, a QA function that has seen fifty of these, and a vendor relationship with leverage behind it.

The mid-market company has none of that. Validation lands on a quality manager who also owns supplier audits and the deviation backlog, or it is outsourced at day rates to a consultancy whose commercial model rewards thoroughness over proportionality. Both routes are expensive, and the second is expensive in a way that is hard to challenge, because almost nobody in the building can judge whether the proposed scope is right.

Where the money actually goes

In our experience the expensive part of a validation project is not the regulatory judgement. Deciding a system's GAMP category, assessing functional risk and choosing a test strategy are genuinely skilled work, and they occupy a small fraction of the hours. The hours go into producing documents: drafting a URS from a vendor specification, writing protocols that follow a predictable structure, formatting evidence, assembling a traceability matrix by hand, and reconciling all of it when a requirement changes.

This is why validation cost tracks document volume rather than system complexity. It also explains why the first instinct — hiring more validation contractors — produces a linear cost increase rather than a step change. You are buying more hands for a task whose bottleneck is assembly, not insight.

What CSA changes, and what it does not

FDA's Computer Software Assurance guidance helps, genuinely. Sizing test effort to the consequence of failure removes a substantial amount of low-value scripted testing, particularly on configured commercial products where the supplier has already tested the core functionality. For a mid-market company with a Category 3 or 4 estate, that is the single largest legitimate reduction available.

But CSA does not reduce the lifecycle documentation. You still need a validation plan, a URS, a risk assessment, protocols, executed records, a traceability matrix and a summary report. The assembly burden — the part that actually consumes the hours — is largely untouched. A company that adopts CSA and expects its validation costs to halve is usually disappointed, and sometimes concludes CSA does not work when the problem was the expectation.

The four levers that actually move the number

First, categorise correctly rather than defensively. Over-categorising a system is the most common and most expensive error we see, and it is usually driven by uncertainty rather than analysis. A Category 4 system wrongly treated as Category 5 can double the document set.

Second, use supplier evidence where you have assessed the supplier. Re-testing what a reputable vendor has already tested, and documented, is pure duplication — but it requires a current supplier assessment, which mid-market companies often skip because it feels like overhead.

Third, attack the assembly burden directly. This is where AI genuinely helps: generating a complete first-draft deliverable set from a structured system description turns weeks of authoring into days of reviewing. The judgement stays human; the typing does not.

Fourth, invest in reusable templates once. Most mid-market companies rebuild their validation documentation from scratch each time because nobody owns the template set. The second system should cost materially less than the first, and if it does not, that is the problem to fix before anything else.

What good looks like

A mid-market company in reasonable shape can validate a configured commercial system without hiring a contractor, in weeks rather than quarters, with a package that survives inspection. The quality manager makes the categorisation and risk decisions, reviews the generated deliverables, and owns the approvals. External help is bought for specific judgement — an unusual system, a remediation, an inspection response — rather than for document production.

That is a realistic target, and it is mostly a function of three things: correct categorisation, a current set of supplier assessments, and removing the assembly bottleneck. None of them require a validation department.